Skip to main content
SpringerLink
Log in

Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - correlations between clinical and morphological features

  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

Histomorphometry was performed on representative trephine biopsies of the bone marrow on admission of 50 patients (21 male, 29 female-age 67 years) with so-called primary osteomyelofibrosis/-sclerosis (OMF) not preceded by any other subtype of chronic myeloproliferative disorders. This study was firstly aimed at testing correlations between histological features (amount of haematopoiesis, cytological aspects of mega-karyocytes, density of reticulin and collagen fibres and degree of osteosclerosis) and laboratory data, as well as spleen size and duration of relevant prediagnostic symptoms. Secondly, we concentrated on a discrimination of OMF patients into two sub-groups according to bone marrow morphology and clinical variables. Statistical evaluation of histomorphometric variables and haematological findings disclosed that there was a progressive fibro-osteosclerotic process in the evolution of disease features. Increase in medullary fibrosis was significantly paralleled by an abnormal or pleomorphic megakaryopoiesis in the bone marrow: there was an increase in irregularity of perimeters for megakaryocytes and naked nuclei combined with smaller sizes of these elements including the nuclei. Additionally, there was a greater number of pycnotic bare nuclei. A number of morphometric features (density of fibres, degree of osteosclerosis, amount of haematopoiesis) were associated with corresponding clinical data (spleen size, length of preclinical history). By consideration of a set of basic histomorphometric variables our co-hort of 50 patients could be divided into an early hyperplastic subtype with no or minimal medullary reticulin and another group with conspicuous fibrotic and osteosclerotic alterations of the bone marrow. It was noticeable that we found no significant correlation between amount of haematopoiesis or marrow cellularity with splenomegaly. This result suggests that splenic haematopoiesis (myeloid metaplasia) may represent an autonomous or neoplastic process and not only compensation for a failing fibro-osteosclerotic bone marrow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arlet Ph, Nicodeme R, Adoue D, Larregain-Fournier D, Delsol G, Le Tallec Y (1984) Clinical evidence for 1,25-hydroxy-cholecalciferol action in myelofibrosis. Lancet I:1013–1014

    Google Scholar 

  • Bentley SA, Herman CJ (1979) Bone marrow fibre production in myelofibrosis: a quantitative study. Br J Haematol 42:51–59

    Google Scholar 

  • Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner B, Mahl G, Sund M (1984) Chronic myeloproliferative disorders (CMPD). Pathol Res Pract 1:131–1868

    Google Scholar 

  • Burkhardt R, Bart R, Jöger K, Frisch B, Kettner B, Mahl G, Sund M (1986) Working classification of chronic myeloproliferative disorders based on histological, haematological and clinical findings. J Clin Pathol 39:237–252

    Google Scholar 

  • Burstein SA, Malpass TW, Yee E, Kadin M, Bridgen M, Adamson JW, Harker LA (1984) Platelet factor 4-excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. Br J Haematol 57:383–392

    Google Scholar 

  • Caligaris Cappio F, Vigliani R, Novarino A, Camussi G, Campagna G, Gavosto F (1981) Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 49:17–21

    Google Scholar 

  • Castro-Malaspina H (1984) Pathogenesis of myelofibrosis: role of ineffective megakaryopoioesis and megakaryocytic components. In: Berk P, Castro-Malaspina H, Wasserman L (eds) Myelofibrosis and the biology of connective tissue. AR Liss, New York, pp 427–454

    Google Scholar 

  • Castro-Malaspina H, Rabellino M, Yen A, Nachman RL, Moore MAS (1981) Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 57:781–787

    Google Scholar 

  • Clough V, Geary CG, Hashmi K, Davson J, Knowlson T (1979) Myelofibrosis in chronic granulocytic leukaemia. Br J Haematol 42:515–526

    Google Scholar 

  • Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372–375

    Google Scholar 

  • Devred C, Diebold J (1974) La myelofibrose au cours des hematopathies. Valeur diagnostique et prognostique. A propos de 402 observations. Sem Hop Paris 50:1625–1634

    Google Scholar 

  • Duhamel G, Najman, Andre R (1970) L'histologie de la moelle osseuse dans la maladie de Vaquez et le probleme de la myelosclerose a propos de 70 biopsies. Nouv Rev Franc Hematol 10:209–222

    Google Scholar 

  • Duncombe AS, Pearson TC, Nunan TO, Miller A, McCarthy DM (1987) 1,25 dihydroxyvitamin D3 (1,25 vit (OH)2, D3) in the treatment of idiopathic myelofibrosis. Br J Hematol 66:579–580

    Google Scholar 

  • Ellis JT, Perterson P, Geller SA, Rappaport H (1986) Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol 23:144–155

    Google Scholar 

  • Fisher RA (1972) Statistical methods for research workers. Oliver & Boyd, Edinburgh

    Google Scholar 

  • Frisch B, Bartl R (1985) Histology of myelofibrosis and osteomyelosclerosis. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 51–86

    Google Scholar 

  • Frisch B, Bartl R, Burkhardt R, Jäger K, Mahl G, Kettner G (1984) Classification of myeloproliferative disorders by bone marrow histology. Bibl Haematol (Basel) 50:57–80

    Google Scholar 

  • Fruchtman SM (1984) Therapeutic implications of the collagen metabolism in myelofibrosis. Prog Clin Biol Res 154:467–474

    Google Scholar 

  • Geary CG (1985) Clinical and hematological aspects of chronic myelofibrosis. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 15–49

    Google Scholar 

  • Georgii A, Vykoupil KF, Thiele J (1984a) Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course. Bibl Haematol (Basel) 50:41–56

    Google Scholar 

  • Georgii A, Vykoupil KF, Thiele J (1984b) Histopathology of bone marrow and clinical findings in chronic myeloproliferative disorders. In: Lennert K and Hübner K (eds) Pathology of the bone marrow. Gustav Fischer Verlag, Stuttgart New York, pp 147–169

    Google Scholar 

  • Gilbert HS (1973) The spectrum of myeloproliferative disorders. Med Clin North Am 57:355–393

    Google Scholar 

  • Gordon BR, Coleman M, Kohen P, Day NK (1981) Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood 58:904–910

    Google Scholar 

  • Greenberg BR, Woo L, Veomett IC, Payne CM, Ahmann FR (1987) Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. Br J Haematol 66:487–490

    Google Scholar 

  • Jacobson RJ, Salo A, Fialkow PJ (1978) Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189–194

    Google Scholar 

  • Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture: a new biopsy device. J Lab Clin Med 77:335–342

    Google Scholar 

  • Kaplan KL, Chao FC, Stiles CD, Antoniades HN, Scher CD (1979) Platelet alpha-granules contain a growth factor for fibroblasts. Blood 53:1043–1052

    Google Scholar 

  • Laszlo J (1975) Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 12:409–432

    Google Scholar 

  • Lazzarino M, Morra E, Castello A, Inveradi D, Coci A, Pagnucco G, Magrini U, Zei G, Bernasconi C (1986) Myelofibrosis in chronic granulocytic leukemia: clinicopathologic correlations and prognostic significance. Br J Hematol 64:227–240

    Google Scholar 

  • Lennert K, Nagai K, Schwarze E-W (1975) Patho-anatomical features of the bone marrow. Clin Hematol 4:331–351

    Google Scholar 

  • Lewis CM, Pegrum GD (1978) Immune complexes in myelofibrosis: a possible guide to management. Br J Haematol 39:233–239

    Google Scholar 

  • Lewis SM (1985) Myelofibrosis: Historical perspective. In: Lewis SM (ed) Myelofibrosis. Pathophysiology and clinical management. Marcel Dekker, New York, pp 1–13

    Google Scholar 

  • Linman JW, Bethell FH (1957) Agnogenic myeloid metaplasia. Am J Med 22:107–122

    Google Scholar 

  • Lohman TP, Beckman EN (1983) Progressive myelofibrosis in agnogenic myeloid metaplasia. Arch Pathol Lab Med 107:593–594

    Google Scholar 

  • MacCarthy DM (1985) Fibrosis of the bone marrow: content and causes. Br J Haematol 59:1–7

    Google Scholar 

  • Monoharan A (1988) Myelofibrosis: prognostic factors and treatment. Br J Hematol 69:295–298

    Google Scholar 

  • Mc Kinley R, Kwan YL, Ford D, Lam-Po-Tang PRI, Mason RS, Manoharan A (1987) Clinical and laboratory studies of 1,25 dihydroxycholecalciferol in myelofibrosis. Br J Hematol 64:252–254

    Google Scholar 

  • Petrini M, Cecconi N, Azzara A, Ambrogi F, Grassi B (1986) 1,25-dihydroxyvitamin D3 (1,25 (OH)2 vit D3) in the treatment of idiopathic myelofibrosis. Br J Hematol 64:624–625

    Google Scholar 

  • Pitcock JA, Reinard EH, Justus BW, Mendelsohn RS (1982) A clinical and pathological study of seventy cases of myelofibrosis. Ann Intern Med 57:73–84

    Google Scholar 

  • Richard C, Mazorra F, Iriondo A, Mazo E, Bello C, Zubizarete A (1986) The usefulness of 1,25-dihydroxyvitamin D 3 (1,25 (OH)2 vit D 3) in the treatment of idiopathic myelofibrosis. Br J Hematol 62:399–400

    Google Scholar 

  • Rondeau E, Solal-Celigny P, Dhermy D, Vroclans M, Brousse N, Bernard JF, Boivin P (1983) Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol 53:467–475

    Google Scholar 

  • Ross R, Vogel A (1978) The platelet-derived growth factor. Cell 14:203–210

    Google Scholar 

  • Rozman C, Vives-Corrons JL, Hernandez-Nieto L, Feliu E, Ester A (1982) Idiopathic myelofibrosis: a possible role of immunological phenomena. Br J Haematol 50:375–376

    Google Scholar 

  • Schaefer HE (1984) How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K, Hübner K (eds) Pathology of the bone marrow. Gustav Fischer Verlag, Stuttgart New York, pp 6–9

    Google Scholar 

  • Schaefer HE Hellriegel KP, Fischer R (1977) Vorkommen von tartratresistenter saurer Phosphatase in verschiedenen Zelltypen des lymphoreticulären und hämatopoetischen Zellsystems. Blut 34:393–397

    Google Scholar 

  • Silverstein MN (1974) Postpolycythemia myeloid metaplasia. Arch Intern Med 134:113–115

    Google Scholar 

  • Silverstein MN (1975) Agnogenic myeloid metaplasia. Publishing Science Group, Acton, Mass

  • Thiele J, Thienel C, Zankovich R, Fischer R (1988) Prognostic features at diagnosis of chronic myeloid leukemia with special emphasis on histological parameters. Med Oncol Tumor Pharmacother 5:49–60

    Google Scholar 

  • Thiele J, Simon K-G, Fischer R, Zankovich R (1988) Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukemia and so-called primary (idiopathic) osteomyelofibrosis. Evolution of histopathological lesions and clinical courses in 40 patients. Pathol Res Pract 183:434–445

    Google Scholar 

  • Ward HP, Block MH (1971) The natural history of agnogenic myeloid metaplasia. Medicine 50:357–420

    Google Scholar 

  • Wasserman LR, Balcerak SP, Berk PD (1981) Influence of therapy on causes of death in polycythemia vera. Trans Assoc Am Physiol 54:30–38

    Google Scholar 

  • Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65:803–809

    Google Scholar 

  • Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hem Pathol 1:77–80

    Google Scholar 

  • Wolf BC, Luevano E, Neiman RS (1983) Evidence that the human fetal spleen is not a hematopoietic organ. Am J Clin Pathol 80:140–144

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, Joseph-Stelzmann-Strasse 9, D-5000, Köln 41, Federal Republic of Germany

    Juergen Thiele, Bert Hoeppner & Robert Fischer

  2. First Clinic of Medicine, University of Cologne, Federal Republic of Germany

    Rudolf Zankovich

Authors
  1. Juergen Thiele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bert Hoeppner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rudolf Zankovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by a grant from the Deutsche Forschungsgemeinschaft (DFG-Th 390/1-1)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Hoeppner, B., Zankovich, R. et al. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - correlations between clinical and morphological features. Vichows Archiv A Pathol Anat 415, 191–202 (1989). https://doi.org/10.1007/BF00724905

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00724905

Key words

Search

Navigation